Patients were identified through electronic medical records and used propensity score matching to compare them with a similar cohort of more than 385,000 patients who had never received GLP-1-RA therapy and did not have a prior AFib diagnosis
There is finally a sense of urgency in this sector and with consolidation and partnership opportunities there will also be winners in the return on investment
"Junk food giants, diet industrys quick fixes, Big Pharmas price-gouging, and regulations that favor special interests have created a system that leaves us with limited options, skyrocketing costs, and a cycle of failure," Hims & Hers said on a site that promotes the ad
Instead of telling your clinician "I was nauseous," you can say "Nausea clustered in the first two days after my Friday shot, usually after larger meals, and improved when I ate smaller protein-first meals and drank more water." That is the kind of summary that makes tracking worth it and the kind your clinician needs to decide whether to step the dose up, hold, or adjust
